v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenues:    
Product sales $ 3,590 $ 5,337
Other revenues 917 796
Total revenues 4,507 6,133
Cost of revenues 2,042 3,227
Gross profit 2,465 2,906
Operating expenses:    
Selling, general and administrative 15,688 18,361
Research and development 2,344 3,267
Total operating expenses 18,032 21,628
Loss from operations (15,567) (18,722)
Other income (expense):    
Interest income 156 375
Change in fair value of warranty liabilities 9,572 (11,986)
Other (36) 113
Total other income (expense), net 9,692 (11,498)
Net loss (5,875) (30,220)
Less: convertible preferred stock dividends (1,218) (392)
Net loss attributable to common stockholders $ (7,093) $ (30,612)
Net loss per basic common share $ (0.16) $ (0.72)
Net loss per diluted common share $ (0.16) $ (0.72)
Weighted average common shares used to compute net loss per basic common share 45,621,214 42,324,190
Weighted average common shares used to compute net loss per diluted common share 45,621,214 42,324,190
Comprehensive loss:    
Net loss $ (7,093) $ (30,612)
Comprehensive loss $ (7,093) $ (30,612)

Source

PDF HTML
ZIP